Search:
All Dates (UTC+8):
  • All
  • 2021-12-11 [Saturday]
  • 2021-12-12 [Sunday]
All Rooms:
  • All
  • Plenary
  • Pulmonology
  • Infectious Diseases
  • Allergy
  • Immunology
  • Pediatric intensive & Critical Care
  • Hematology & Oncology
  • Neurology
  • Child Health Care & Developmental Behavior
  • Endocrinology
  • Sleep
  • Clinical Epidemiology
  • Gastroenterology & Nutriolog
  • Nephrology
  • Radiology
  • Cardiology
  • In Utero Pediatrics
  • Early Childhood Development
  • Rare Diseases
  • Clinical Pharmacology
  • Nursing
  • Dermatology
  • Disaster Preparedness
  • Psychology & Mental Health
  • Neonatology
  • Epigenetics & Physical Activity
  • Young Investigators
  • Oral Presentation1&3
  • Oral Presentation 2

In Utero Pediatrics

2021-12-12 (UTC+8) Sun 2021-12-12 Local Time

09:35-10:55 (UTC+8) 09:35-10:55 Local Time | In Utero Pediatrics(a.m.)
NO. Beijing Time (UTC+8) Local Time Type Presentation Topic Speaker
1 09:35-09:40 09:35-09:40 Welcome Speech

Session Chair Speech

Kun Sun
2 09:40-10:00 09:40-10:00 Symposium

In-Utero Pediatrics, How the In-Utero Environment Influences Child Health

Mark Walker
3 10:00-10:20 10:00-10:20 Symposium

Advancing Pediatric Care before Birth-Formalize In utero Pediatrics

Kun Sun
4 10:20-10:40 10:20-10:40 Symposium

The influence, mechanism and intervention of environmental exposure during pregnancy and early life on children's neurological outcome

Fei Li
5 10:40-10:55 10:40-10:55 Comment

Discussion

11:05-12:20 (UTC+8) 11:05-12:20 Local Time | In Utero Pediatrics(a.m.)
NO. Beijing Time (UTC+8) Local Time Type Presentation Topic Speaker
1 11:05-11:25 11:05-11:25 Symposium

Abnormal Fetal Programming Prenatal and Postnatal Restoration

Jun Zhang
2 11:25-11:45 11:25-11:45 Symposium

Fetal Stem Cell and Gene Therapies for Genetic Disease: Challenges and Potential

Citra Mattar
3 11:45-12:05 11:45-12:05 Symposium

Prenal diagnosis and fetal therapy of non-immune fetal hydrops : a single-center experience in China

Luming Sun
4 12:05-12:20 12:05-12:20 Comment

Discussion